Gait bradykinesia, a basic sign in PD, affects almost all patients and may lead to a substantial disability. [7] [8] [9] The gait cycle is compromised, with loss of mobility and consequently loss of functional independence. Both the ability of drawing up the gait and the activation of the motor control system are affected in the disease. Patients compensate the reduction in walking speed associated with reduced stride length by increasing the cadence, leading to the parkinsonian gait. [10] [11] [12] Physical therapy is an intervention that prioritizes the improvement of functional limitations and physical disabilities. 13 , 14 Gait training is essential for the restoration of function. For learning and memory consolidation of a given motor task, repeated training is required, as the application of a constant and repetitive stimulus will lead to permanent changes in the ability to move. 4 , 15 The treadmill is widely used as a gait analysis and training method in general practice and research, especially for patients who had a stroke. 16 It facilitates the execution of different gait cycles without changing the natural gait performance. 17 Walking on a treadmill is not a simple experience, requiring an appropriate familiarization. 16 Safety is obtained if individuals have enough time for training. A body weight-supported treadmill training (BWSTT) can be used in patients with neurological diseases to promote a functional ambulation. 9 , 18 The BWSTT symmetrically removes the weight on the lower limbs, facilitating the gait in patients without the ability to walk otherwise. 12 , 19 , 20 The device allows patients in an early stage of functionality to practice the complete walking cycle with several repetitions instead of simpler gait elements trained by other methods. [21] [22] [23] The most important characteristics of gait training are the specifi city and the rhythmicity. Since repetitive patterns of movement are natural constituents of the gait, rhythm is an important trait in locomotion. The treadmill allows a constant and rhythmic training, offering ideal conditions for the reproduction of the specifi c movements involved in a steady gait. 4 The objective of this study is to test the hypothesis that BWSTT is superior to conventional physical therapy (CPT) for gait improvement in patients with PD.
T he natural progression and the great diversity of symptoms make Parkinson disease (PD) a complex disorder that challenges health professionals. Despite advances in pharmacologic therapy and surgical procedures, therapeutic options for these patients are limited. The development of better physical therapy interventions is important for gait rehabilitation and welfare of patients with PD.
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The human locomotion is made of integrated and complex movements of several body segments. Effectiveness depends on the combination of a proper central processing, effective afferent information, and suitable efferent structures. Any failure during human development or
MATERIALS AND METHODS
This is a prospective controlled study carried out at the Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, approved by the local ethics committee. A written informed consent was obtained from all subjects enrolled in this study.
The control group consisted of 40 healthy volunteers of both genders (21 females), with their age matched to the experimental group age. This group established a standard of normality for the equipment of own manufacture by walking once for 10 minutes with 20% and 10% of their body weight suspended with 5 minutes of rest between sessions. The initial speed was 1.0 km/h, increased by 0.5 km/h every 2 minutes until a maximum of 3.0 km/h, according to tolerance. 14 , 24 Fatigue was measured using the Borg Scale, and the cadence (number of steps per minute) was analyzed according to age group.
The patient group was composed by 42 patients of both genders with PD (10 females), aged 46 to 85 years, all in early stages of the disease (2-3 at the Hoehn and Yahr Modifi ed Scale), 25 and with at least 5 years of disease duration. During the research, the drugs remained unchanged. Patients were randomly divided into 2 subgroups: 24 patients received CPT treatment consisting of gait training, stretching, muscle strength exercises, and cognitive abilities, and 18 patients underwent treatment with BWSTT similarly to the control group. Treatments lasted 3 months, with 25 minutes for each session, totaling 24 sessions for each group.
The study excluded patients and volunteers who showed orthopedic, rheumatologic, and other neurological and/or cardiopulmonary problems that would interfere with the gait and patients with PD with freezing phenomenon. No patient presented ON-OFF phenomena.
Before starting the protocol, subjects were assessed by the Unifi ed Parkinson's Disease Rating Scale (UPDRS) and the following tests were performed: gait speed, cadence assessment, Timed Up and Go, and 6-minute walk test (6-WT). To measure the gait speed, we asked all participants to walk normally through a corridor, with markers at 0, 2, 8, and 10 m. The time span was recorded from the second to third mark. Each participant repeated the test 3 times, the fi nal gait speed being obtained from the number of seconds the participant took to walk that distance in all 3 attempts divided by 18. 26 To perform the Timed Up and Go (mobility assessment), participants should sit on a standard armchair and walk to a line 3 m away, turn around, walk back, and sit. 27 The 6-WT (functional exercise capacity assessment) was carried out in a 30-m length corridor, the total distance covered being recorded for analysis. Participants used their usual walking aids, if necessary. 28 In the fi rst and last BWSTT sessions, cadence and fatigue levels with 20% and 10% of the body weight suspension at each speed were recorded. After 3 months, patients in BWSTT and CPT groups were reassessed with the same protocol.
Data were shown as mean ± standard deviation. Student t test was used for comparisons, with P values of .05 or less considered signifi cant (GraphPad Prism version 5.0 for Windows, GraphPad Software, San Diego, California). Table 1 shows the anthropometric, demographic, and clinical data for the CPT, BWSTT, and control groups.
RESULTS
In relation to fatigue, the Borg Scale showed a statistically signifi cant difference between the control group and the BWSTT group at the fi rst session, with 20% of body weight at the 2nd ( P = .04), 4th ( P = .04), 6th ( P = .03), and 10th minute ( P = .02), with a nonsignifi cant difference at 8th minute ( P = .06). When the fi rst and last sessions for the BWSTT group were compared, a statistically signifi cant decrease at 4th ( P = .05), 6th ( P = .01), 8th ( P = .002), and 10th minute ( P = .001) was noticed, with no signifi cance at the fi rst minute ( P = .09). With 10% of body weight, the difference was found comparing the fi rst session with the last session only in the BWSTT group at 2nd ( P = .02), 4th ( P = .005), 6th ( P = .001), 8th ( P = .01), and 10th minute ( P = .003). Between control and BWSTT (fi rst session) groups, there were no statistical differences at 2nd ( P = .19), 4th ( P = .17), 6th ( P = .26), 8th ( P = .21), and 10th minute ( P = .08) ( Table 2 ) . Cadence was signifi cantly reduced comparing control and BWSTT (fi rst session) groups at 2nd minute ( P < .02) and between BWSTT (fi rst vs last session) at 4th ( P = .02) and 10th minute ( P = .05) with 20% of body weight. Considering 10% of body weight, signifi cant differences were observed between control and BWSTT (fi rst session) groups at 2nd ( P = .004) minute ( Table 3 ) .
The UPDRS improved comparing BWSTT at fi rst and last sessions (52.11 ± 21.15 vs 48.33 ± 20.64; P = .02). Differences were not signifi cant between CPT at fi rst (54.71 ± 21.92) and last sessions (55.21 ± 19.52) ( Figure 1A ) .
The gait speed analysis showed a statistically signifi cant increase between CPT fi rst and last sessions (0.89 ± 0.30 vs 0.94 ± 0.29; P = .02). The values in the fi rst session were higher than those in the last session for the CPT group (1.13 ± 0.24 vs 0.94 ± 0.29; P = .0005), as well as for the BWSTT group at last session compared with CPT group at last session (1.25 ± 0.32 vs 0.89 ± 0.30; P = .0005). However, we did not observe a signifi cant difference between fi rst and last sessions of the BWSTT group ( Figure 1B ) Figure 1D ) .
A signifi cant 6-WT improvement in the CPT group was observed comparing baseline with values after intervention (393.0 ± 51.37 vs 412.2; P = .004). No similar statistical differences were noticed in the BWSTT group (before: 411.8 ± 104.1; after: 420.5 ± 92.66) ( Figure 1E ). Finally, there were no signifi cant changes in Borg Scale values (CPT and BWSTT before treatment: 2.29 ± 1.94 vs 2.33 ± 2.05, P > .05; and CPT and BWSTT after intervention: 2.58 ± 1.71 vs 2.25 ± 1.73, P > .05) ( Figure 1F ).
DISCUSSION
This study confi rmed that physiotherapy may be pivotal in PD, but the BWSTT does not represent a signifi cant advantage as compared with conventional treatment.
Age affected gait signifi cantly. Our fi ndings are in line with other studies that highlight the action of aging on the physical skills, especially with regard to locomotion. [29] [30] [31] [32] [33] [34] The results suggest that the aging-associated gait changes are also seen with the use of a hanger device.
The theoretical basis for BWSTT is the activation of the central pattern generator (CPG) in the spinal cord. This ; (E) 6-minute walk test (s); and (F) Borg Scale at 6-minute walk test. BWSTT indicates body weight-supported treadmill training; CPT, conventional physical therapy; UPDRS, Unifi ed Parkinson's Disease Rating Scale. Error bars represent standard deviations, except for UPDRS, expressed as median with range. * P < .05; ** P < .01; *** P < .001. represents an important component in the circuitry that controls posture and movement. In humans, the CPGs are evidenced during movement of the lower limbs by the gait refl ex. Despite the fact that the human gait requires a greater degree of downward motor control because of complex postural adjustments, the elucidation of the CPGs' dynamics is of great importance for locomotion rehabilitation. 4 , 35 Since PD is a disorder that involves an encephalic rather than spinal motor control defi ciency, the possibility exists that BWSTT could activate the spinal CPG as well other alternative motor control systems in a way to help patients to overcome their locomotion fl aw.
The Borg Scale values increased in the control group after 10 minutes of treadmill walking regardless of age. This was expected, as fatigue increases with the walking speed and time span. It was also observed that older individuals reached comparatively higher values, especially with 10% drop in body weight, at the end of the treatment session. This indicates that older subjects get tired more easily because of the fact that during the walk at a normal speed, the elderly consume signifi cantly more oxygen. 36 Concerning cadence, the mean values increased with speed in all age groups, both at 20% and 10% of body weight suspension, indicating that the higher the speed, more steps are required to maintain the walking rhythm. The cadence rate correlated positively with age, which is explained by the fact that older subjects have greater step and stride time variability. 31 The Borg Scale values in patients with PD at the beginning of treatment with body weight support suggest that patients with PD got comparatively more tired, refl ecting the gait diffi culties in this group. These patients consume about 6% to 10% more energy than healthy individuals for walking. 37 The low energy saving during gait is probably the result of physical changes due to the commitment of the disease. 37 , 38 Our results indicate higher degrees of fatigue in patients with PD at 20% drop in body weight than those patients with only 10% drop in body weight. We hypothesize that this is due to our methodology, as the 20% body weight suspension is tested fi rst. Besides, familiarization with the procedures could make later results comparatively better. 16 The Borg values decreased after the body weight support treadmill treatment in the PD group. Patients reported feeling less tired at the end of treatment, especially with 10% of body weight suspension. This may also be related to adaptation with the method.
The patients with PD took fewer steps during BWSTT. This was signifi cant only at the beginning of the walk because, as speed increases, both patients and healthy individuals could control the pace of cadence accordingly, causing the number of steps to get similar.
The UPDRS improved signifi cantly following the BWSTT, concerning especially the subactivities of daily living and motor exploration. This indicates that physical outcomes in patients with PD submitted to BWSTT can be observed using the UPDRS. Besides, the UPDRS can be useful to detect general changes in motor aspects. 39 For the group that underwent CPT, the gait velocity increased after treatment. Therefore, improvement did not depend on the speed imposed by treadmill and could occur at spontaneous rhythm. This group also showed improved performance over distance on the 6-WT.
This study has shortcomings. The method did not include a crossover design, possibly leading to a training effect. Besides, the relatively limited number of subjects could have infl uenced the results.
CONCLUSION
Comparing BWSTT with the conventional approach, no technique proved signifi cantly better than the other. The question remains as whether their combination could improve patients with PD even further. Further studies are needed to fi nd the best treatment protocol to achieve good results in the variables of the gait of these patients, for example, testing different percentages of the body weight suspension in different groups composed by patients with PD.
